References

Cetaphil® product group
  1. 21-day Cumulative Irritancy Study. Cantor Research Laboratories, Inc. Data on file, Galderma.
  2. 2 Week Open Label Clinical Assessment of Hydrolipidic Barrier. Stevens & Associates. Data on file, Galdema.
  3. Mini-regression Moisturisation Study, Stephen & Associates. Colorado Research Centre. Data on File, Galderma.
  4. Data on File, Galderma.
  5. Australia and New Zealand sunscreen standard -AS/NZS 2604: 2012 ‘very high’.
  6. Simpson E etal-Journ Drugs Dermatol, 2011: 10(7): 744-9
  7. www.eczema.org.au

Cetaphil ® and Restoraderm™ are registered trademark of Galderma Australia.

Miracare® registered trademark Rhodia.